期刊文献+

脊柱外科手术中氨甲环酸的应用 被引量:2

Application of tranexamic acid in spinal surgery
下载PDF
导出
摘要 随着科学技术的不断进步,脊柱这一曾经的手术禁区,目前已取得较好的手术疗效,例如上颈椎(寰枢椎)、先天性脊柱侧弯、脊柱结核及肿瘤等复杂手术。尽管如此,在脊柱手术过程中仍因为手术节段多、剥离组织肌肉多,导致术区出血量较大,影响手术效果。氨甲环酸是一种纤溶酶抑制剂,通过竞争性抑制纤溶酶原激活因子,从而阻断纤溶酶原激活为纤溶酶起到抗纤溶的作用。现广泛应用于普外科、胸外科及妇产科等,本文就氨甲环酸应用于脊柱外科研究进展作一综述。 With the continuous advancement of science and technology,the spine,a former surgical exclusion zone,has achieved good surgical outcomes,such as the upper cervical spine(axial atlanto),congenital scoliosis,spinal tuberculosis and tumors.However,during the spinal surgery,because of the large number of surgical segments and the removal of tissue muscles,the amount of bleeding in the operation area is large,which affects the surgical results.Tranexamic acid is a plasmin inhibitor that inhibits the activation of plasminogen to act on plasmin to prevent fibrinolysis by competitively inhibiting plasminogen activator.It is widely used in general surgery,thoracic surgery and obstetrics and gynecology.The following is a summary of the research progress of tranexamic acid in spinal surgery.
作者 张裕 潘健 刘午阳 ZHANG Yu;PAN Jian;LIU Wu-yang(Gannan Medical University,Ganzhou,Jiangxi 341000;The First Affiliated Hospital,Ganzhou,Jiangxi 341000)
出处 《赣南医学院学报》 2019年第9期964-966,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 氨甲环酸 脊柱外科 给药途径 剂量 Tranexamic acid Spine Surgery Route of administration dose
  • 相关文献

参考文献8

二级参考文献130

  • 1DALMAU A,SABATE A, ACOSTA F,et al. Tranexamic acid reduces red cell transfusion better than epsilon- amincaproic acid or placebo in liver transplantation [J]. Anesth Analg, 2000,91(1) :29-34.
  • 2WONG J,EI BEHEIRY H,RAMPERSAUD Y R,et al. Tranexamic acid reduces peri operative blood loss in adult patients having spinal fusion surgery [J]. Anesth Analg, 2008 , 107 ( 5 ) : 1479-1486.
  • 3ELWATIDY S,JAMJOOM Z,ELGAMAL E,et al. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospectiverandomized double- blind placebo- controlled study [J]. Spine (Phila Pa 1976) ,2008,33(24) :2577-2580.
  • 4ELGAFY H, BRANSFORD R J, McGUIRE R A, et al. Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery?.
  • 5KOTANI N, HASHIMOTO H, SESSLER D I, et al. Cardiopulmo- nary bypass produces greater pulmonary than systemic proin- flammatory cytokines [ J ]. Anesth Analg,2000,90 : 1039-1045.
  • 6TORRE D, TAMBINI R, ARISTODEMO S, et al. Anti- inflam- matory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome [ J ]. Mediators In- flamm,2000,9 (3-4) : 193-195.
  • 7Cardone D, Klein AA. Perioperative blood conser- vation[J]. Eur J Anaesthesiol, 2009, 26(9): 722- 729.
  • 8Cooper JR, Abrams J, Frazier OH, et al. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy [J]. J Thorae Cardiovasc Surg, 2006, 131(5): 963-968.
  • 9Mangano DT, Miao Y, Vuylsteke A, et al. Mortal-ity associated with aprotinin during 5 years follow- ing coronary artery bypass graft surgery[J]. JA- MA, 2007, 297(5): 471-479.
  • 10McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis[J]. Drugs, 2012, 72(5): 585-617.

共引文献42

同被引文献28

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部